Reaction

Disseminated Mucormycosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 383 reports · 50 co-occurring drugs

As of the last recalculation, Disseminated Mucormycosis appears in 383 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 296.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amphotericin B	58	296.3	297.7
Micafungin Sodium	32	223.7	224.6
Voriconazole Injection	69	210.4	211.1
Basiliximab	32	161.3	161.7
Voriconazole	69	150.4	150.7
Mycophenilic Acid	49	147.2	147.6
Tacrolimus Ointment 0.1%	171	134.0	134.2
Tacrolimus Extended-Release Capsules	171	133.6	133.8
Tacrolimus	176	112.1	112.3
Meropenem	51	99.5	99.6
Mycophenolic Acid	49	95.3	95.4
Busulfan	24	88.4	88.5
Ganciclovir	15	82.9	83.0
Posaconazole Delayed-Release	16	82.6	82.7
Ganciclovir Sodium	15	80.1	80.2
Fludarabine Phosphate	49	77.5	77.6
Anakinra	22	76.4	76.5
Fluconazole	74	70.9	71.0
Piperacillin And Tazobactam	14	61.7	61.8
Levofloxacin	57	60.2	60.2
Levofloxacin In 5% Dextrose	57	60.2	60.2
Valganciclovir Hydrochloride Powder,	13	59.9	60.0
Mycophenolate Mofetil Hydrochloride	108	59.7	59.7
Cefepime	15	59.1	59.2
Mycophenolate Mofetil	106	58.3	58.3
Vancomycin	52	56.4	56.5
Posaconazole	16	55.8	55.9
Atovaquone	8	55.1	55.2
Anti-Thymocyte Globulin (Rabbit)	8	55.0	55.1
Piperacillin Sodium,Tazobactam Sodium	25	54.7	54.8
Daptomycin	9	54.3	54.3
Vancomycin Hydrochloride	55	52.8	52.8
Cefepime Hydrochloride	15	52.6	52.7
Remdesivir	12	50.5	50.5
Norepinephrine	9	46.8	46.9
Ceftriaxone	26	46.1	46.2
Itraconazole	9	42.9	42.9
Gentamicin	10	42.6	42.7
Cefazolin	7	42.5	42.5
Ceftriaxone Sodium	27	41.1	41.1
Piperacillin Sodium And Tazobactam Sodium	14	40.2	40.2
Gentamicin Sulfate	11	38.9	39.0
Valganciclovir	13	38.8	38.8
Valganciclovir Hydrochloride	13	38.8	38.8
Blinatumomab	7	37.1	37.1
Bendamustine Hcl	10	36.0	36.0
Norepinephrine Bitartrate	9	34.8	34.8
Isoniazid	10	34.4	34.4
Ruxolitinib	24	19.4	19.4
Azacitidine For	6	18.2	18.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.